
1. malar j. 2016 aug 24;15(1):429. doi: 10.1186/s12936-016-1485-1.

non-falciparum malaria dakar: confirmed case plasmodium ovale wallikeri
infection.

diallo ma(1), badiane as(2), diongue k(2), deme a(2), lucchi nw(3), gaye m(2),
ndiaye t(2), ndiaye m(2), sene lk(2), diop a(2), gaye a(2), ndiaye yd(2), samb
d(2), yade ms(2), ndir o(2), udhayakumar v(3), ndiaye d(2).

author information: 
(1)laboratoire de parasitologie-mycologie, université cheikh anta diop de dakar, 
avenue cheikh anta diop, fann, bp 5005, dakar, senegal.
mamadoualpha.diallo@ucad.edu.sn.
(2)laboratoire de parasitologie-mycologie, université cheikh anta diop de dakar, 
avenue cheikh anta diop, fann, bp 5005, dakar, senegal.
(3)malaria branch, division parasitic diseases malaria, center global 
health, centers disease control prevention, atlanta, ga, usa.

background: plasmodium ovale rarely described senegal. case clinical
malaria due p. ovale wallikeri west central senegal reported.
case: 34-year-old male baker dakar, significant previous medical
history, admitted health clinic fever vomiting. fever 
lasting 4 days peaks every 48 h. monospecific plasmodium falciparum
hrp-2 rdt was negative, treated antibiotics. however, owing to
persisting symptoms, referred emergency unit youssou
mbargane diop hospital, dakar, senegal. clinical examination found impaired
general condition. physical examinations normal. laboratory tests 
showed anaemia (haemoglobin 11.4 g/dl), severe thrombocytopaenia (platelets
30 × 10(9)/mm(3)), leukopenia (3650/mm(3)), lymphocytopenia (650/mm(3)). renal
function normal indicated creatininaemia uraemia (11 mg/l and
0.25 g/l, respectively) liver enzymes slightly elevated (aspartate
aminotransferase 77 ui/l alanine aminotransferase 82 ui/l). blood smear
evaluations parasitology laboratory aristide le dantec hospital showed
malaria parasites species p. ovale 0.08 % parasitaemia. molecular
confirmation done real time pcr targeting 18s rrna gene. p. ovale 
infection analysed species level targeting potra gene 
identified p. ovale wallikeri. according hospital's malaria treatment
guidelines severe malaria, treatment consisted intravenous quinine hour
0 (start treatment) 24 h initial treatment, followed by
artemether-lumefantrine 24 h later. negative microscopy noted day 3
post-treatment patient reported symptoms.
conclusion: malaria due non-falciparum species probably underestimated in
senegal. rdts specific non-falciparum species and/or pan specific rdts 
be included tools diagnosis fight malaria senegal. in
addition, field-deployable molecular tool loop-mediated isothermal 
amplification considered additional useful tool detect low
malaria parasite infections speciation. addition, national malaria
control policies consider non-falciparum species treatment
guidelines, including provision primaquine treatment relapsing 
parasites.

doi: 10.1186/s12936-016-1485-1 
pmcid: pmc4997729
pmid: 27557982  [indexed medline]

